Skip to main content
Top
Published in: Rheumatology International 1/2014

01-01-2014 | Short Communication

The detection of calcium pyrophosphate crystals in the synovial fluid of patients with rheumatoid arthritis using the cytospin technique: prevalence and clinical correlation

Authors: Georg Theiler, Franz Quehenberger, Franz Rainer, Manfred Neubauer, Mariana Stettin, Christoph Robier

Published in: Rheumatology International | Issue 1/2014

Login to get access

Abstract

There are only a few studies dealing with the detection and clinical impact of calcium pyrophosphate (CPPD) crystals in patients with rheumatoid arthritis (RA) published to date. In particular, data determined by the cytospin technique, which is an effective tool to enhance the crystal detection rate, are lacking. The objectives of this study were to determine the prevalence of CPPD crystals in the synovial fluid (SF) of patients with RA and to investigate whether the detection of CPPD crystals is correlated with demographic, clinical and serological features. We examined 113 consecutive SF samples of patients with RA, obtained from therapeutic arthrocentesis of knee joints. After cytocentrifugation, the sediments were examined by polarized microscopy for the occurrence of CPPD crystals. Demographic, clinical and serological data, acquired from the medical records, were compared between crystal-positive and crystal-negative subjects. CPPD crystals were observed in 20 of the 113 cases, representing 17.7 %. CPPD-positive and CPPD-negative subjects did not differ significantly in sex, duration of disease, Steinbrocker radiologic stage, disease activity score 28, as well as serum rheumatoid factor and anti-CCP positivity. Patients positively tested for CPPD crystals had a significantly higher age than CPPD-negative patients (p < 0.0001). An age-independent association of long-time treatment with diuretics and CPPD crystal formation was not found. In conclusion, demographic, clinical and serological characteristics of patients with RA were not associated with the occurrence of CPPD crystals. Age was the only significant influencing factor on CPPD crystal formation in patients with RA.
Literature
1.
go back to reference Pascual E (1996) The diagnosis of gout and CPPD crystal arthropathy. Br J Rheumatol 35(4):306–308PubMedCrossRef Pascual E (1996) The diagnosis of gout and CPPD crystal arthropathy. Br J Rheumatol 35(4):306–308PubMedCrossRef
2.
go back to reference Richette P, Bardin T, Doherty M (2009) An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology 48:711–715PubMedCrossRef Richette P, Bardin T, Doherty M (2009) An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology 48:711–715PubMedCrossRef
3.
go back to reference Doherty M, Dieppe P, Watt I (1984) Low incidence of calcium pyrophosphate dihydrate crystal deposition in rheumatoid arthritis, with modification of radiographic features in coexistent disease. Arthritis Rheum 27(9):1002–1009PubMedCrossRef Doherty M, Dieppe P, Watt I (1984) Low incidence of calcium pyrophosphate dihydrate crystal deposition in rheumatoid arthritis, with modification of radiographic features in coexistent disease. Arthritis Rheum 27(9):1002–1009PubMedCrossRef
4.
go back to reference Gerster JC, Varisco PA, Kern J, Dudler J, So AKL (2006) CPPD crystal deposition disease in patients with rheumatoid arthritis. Clin Rheumatol 25:468–469PubMedCrossRef Gerster JC, Varisco PA, Kern J, Dudler J, So AKL (2006) CPPD crystal deposition disease in patients with rheumatoid arthritis. Clin Rheumatol 25:468–469PubMedCrossRef
5.
go back to reference Robier C, Neubauer M, Quehenberger F, Rainer F (2011) Coincidence of calcium pyrophosphate and monosodium urate crystals in the synovial fluid of patients with gout determined by the cytocentrifugation technique. Ann Rheum Dis 70(6):1163–1164PubMedCrossRef Robier C, Neubauer M, Quehenberger F, Rainer F (2011) Coincidence of calcium pyrophosphate and monosodium urate crystals in the synovial fluid of patients with gout determined by the cytocentrifugation technique. Ann Rheum Dis 70(6):1163–1164PubMedCrossRef
6.
go back to reference Von Essen R, Hölttä AMH, Pikkarainen R (1998) Quality control of synovial fluid crystal identification. Ann Rheum Dis 57:107–109CrossRef Von Essen R, Hölttä AMH, Pikkarainen R (1998) Quality control of synovial fluid crystal identification. Ann Rheum Dis 57:107–109CrossRef
7.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324PubMedCrossRef
8.
go back to reference Steinbrocker O, Traeger CH, Battermann RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662CrossRef Steinbrocker O, Traeger CH, Battermann RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662CrossRef
9.
go back to reference Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48PubMedCrossRef Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48PubMedCrossRef
10.
go back to reference Sany J, Rosenberg F, Bataille R, Serre H (1977) Chondrocalcinoses secondaires et associees. Rev Rhum 44:565–577PubMed Sany J, Rosenberg F, Bataille R, Serre H (1977) Chondrocalcinoses secondaires et associees. Rev Rhum 44:565–577PubMed
11.
go back to reference Neame RL, Carr AJ, Muir K, Doherty M (2003) UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis 62:513–518PubMedCrossRef Neame RL, Carr AJ, Muir K, Doherty M (2003) UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis 62:513–518PubMedCrossRef
12.
go back to reference Felson DT, Anderson JJ, Naimark A, Kannel W, Meenan RF (1989) The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol 16:1241–1245PubMed Felson DT, Anderson JJ, Naimark A, Kannel W, Meenan RF (1989) The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol 16:1241–1245PubMed
13.
go back to reference Ivorra J, Pascual E (1999) Most calcium pyrophosphate crystals appear as non-birefringent. Ann Rheum Dis 58:582–584PubMedCrossRef Ivorra J, Pascual E (1999) Most calcium pyrophosphate crystals appear as non-birefringent. Ann Rheum Dis 58:582–584PubMedCrossRef
14.
go back to reference Whiting PF, Smidt N, Sterne JA, Harbord R, Burton A, Burke M et al (2010) Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med 152(7):456–464PubMedCrossRef Whiting PF, Smidt N, Sterne JA, Harbord R, Burton A, Burke M et al (2010) Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med 152(7):456–464PubMedCrossRef
Metadata
Title
The detection of calcium pyrophosphate crystals in the synovial fluid of patients with rheumatoid arthritis using the cytospin technique: prevalence and clinical correlation
Authors
Georg Theiler
Franz Quehenberger
Franz Rainer
Manfred Neubauer
Mariana Stettin
Christoph Robier
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 1/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2608-9

Other articles of this Issue 1/2014

Rheumatology International 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine